Clinical toxicology of sedative-hypnotics

Slides:



Advertisements
Similar presentations
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 34 Sedative-Hypnotic Drugs.
Advertisements

CNS Depressants: Sedative-Hypnotics Chapter 6
DR. SHABANA ALI. Adverse Drug Reactions (ADR) Harm associated with the use of a given medications OR Unwanted or harmful reaction experienced after the.
BARBITURATE & BENZODIAZEPINE POISONING
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Antianxiety Agents.
Sedative-Hypnotic Drugs
Sedatives and Hypnotics
SEDATIVES/HYPNOTICS BY KIMBERLY ROEMER. HISTORY OF SEDATIVES Sedatives have been around since the 1800’s. Potassium Bromide was used in 1830 as a sedative.
 BNZ-1 r.: sedation, hypnotic, antianxiety  BNZ-2 r.: anxiolysis, muscle relaxation, sedation, anticonvulsant, psychomotor impairment  BNZ-3 r.: tolerance,
Sedatives – Hypnotics.  1) CNS depressants are usually not obtained illicitly and self-administered but rather are prescribed under the direction of.
PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES
Prepared by : Areen Zraikah Dana Fatayer. Pharmacology: Naloxone and nalmefene are pure opioid antagonists that competitively block mu, kappa, and delta.
CNS Depressants: Sedative-Hypnotics Chapter 6
Sedative-Hypnotics Teresita N. Avendano-Batanes, M.D., DPBA
Sedatives & Hypnotics. Sedatives The perfect sedative reduces anxiety with little or no effect on motor or mental function within the therapeutic dosing.
HYPNOTICS AND SEDATIVES
Chapter 27 Central Nervous System Sedatives and Hypnotics.
Sedative-Hypnotic Drugs -----prescribed to cause sedation (for patients with anxiety) or to encourage sleep (for patients with insomnia)
Sedative-Hypnotic Drugs
Sedative & Hypnotics By Prof. Dr. Hanan Hagar.
Tranquilizers & Sedative-Hypnotics
Drugs Used in Mental Health Antianxiety Drugs. Anxiety – a feeling of apprehension, worry, or uneasiness that may or may not e based on reality Anxiolytics.
Drugs used in Anxiety & Panic Disorders
Age Changes By Sue Henderson.
Sedative-Hypnotic Drugs
Chapter 27 Central Nervous System Sedatives and Hypnotics.
Anxiolytics-Sedatives -Hypnotics. Definitions Anxiolytics: are drugs which reduce anxiety. Sedatives: A drug that reduces a person’s response to most.
600 Hypnotics association with Mortality Charles Heaney 19/02/2013.
Anxiolytic , Sedative and Hypnotic Drugs
Drugs acting on the CNS. Nervous System CNS PNS Somatic Autonomic Parasympathetic Sympathetic.
MHD & Therapeutics is proud to present And Now Here Is The Host... Insert Name Here.
CNS Depressants: Sedative- Hypnotics Chapter 6. Introduction to CNS Depressants Why are CNS depressants problematic? -Usually prescribed under physician’s.
Drugs used for anxiety and panic disorders
Drugs used for anxiety and panic disorders
Benzodiazepines Rachel Anderson.
Sedative-Hypnotic Drugs
Substance-Related AND Addictive Disorders/Drug Abuse
Barbiturates Meprobamate Paralehyde Chloral hydrate
Pharmacology Tutoring for Sedative Hypnotics and Antiemetics
Effects of Medication Therapeutic Effects=Desired or intended effects of medication – refers to the primary purpose of prescribing and administrating medication.
Drugs for Anxiety and Insomnia
Sedative-Hypnotic Drugs
Chapter 38 Drug Abuse II: Alcohol 1.
Drugs used in generalized seizures
Barbiturates 4th Year Pharmacy
Other drugs used in the treatment of bipolar disorder
Sedative-hypnotic drugs part I
Drugs Affecting the Central Nervous System
Tremor Domina Petric, MD.
Domina Petric, MD Huntington´s disease.
Drug-induced dyskinesias
Clinical pharmacology of sedative-hypnotics
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Anxiolytic and Hypnotic drugs
Anxiolytic, Sedative and Hypnotic Drugs
Pharmacodynamics of benzodiazepines, barbiturates and newer hypnotics
CNS Depressants: Sedative-Hypnotics Chapter 6
NSAIDs 4th stage students
Anxiolytic and hypnotic drugs
CNS Depressants: Sedative-Hypnotics Chapter 6
Anxiolytic, Sedative and Hypnotic Drugs
فلوشیپ سم شناسی بالینی عضو هیئت علمی دانشکده پزشکی
ADDICTION
Anxiolytics.
High-Yield Terms to Learn Abstinence syndrome  A term used to describe the signs and symptoms that occur on withdrawal.
Canadian National Institute of Health Inc.
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Sedatives and Hypnotics #1
Presentation transcript:

Clinical toxicology of sedative-hypnotics Domina Petric, MD

Direct toxic actions Many of the common adverse effects of sedative-hypnotics result from dose-related depression of the CNS. Relatively low doses may lead to drowsiness, impaired judgment and diminished motor skills. This can lead to a significant impact on driving ability, job performance and personal relationships. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions Sleep driving and other somnambulistic behavior with no memory of the event have occurred with the sedative-hypnotic drugs. Benzodiazepines may cause a significant dose-related anterograde amnesia. They can significantly impair ability to learn new information, particularly that involving effortful cognitive processes. Retrieval of previously learned information is intact with benzodiazepines. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions The criminal use of benzodiazepines in cases of ˝date rape˝ is based on their dose-dependent amnestic effects. Hangover effects are not uncommon following use of hypnotic drugs with long elimination half-lives. Elderly patients are more sensitive to the effects of sedative-hypnotics. Doses approximately half of those used in younger adults are safer for elderly patients and usually as effective. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions The most common reversible cause of confusional states in the elderly is overuse of sedative-hypnotics. At higher doses, toxicity may present as lethargy or a state of exhaustion. An increased sensitivity to sedative-hypnotics is more common in patients with cardiovascular disease, respiratory disease and hepatic impairment. Sedative-hypnotics can exacerbate breathing problems in patients with chronic pulmonary disease and in those with symptomatic sleep apnea. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions Sedative-hypnotics are the drugs most frequently involved in deliberate overdoses. The benzodiazepines are considered to be safer drugs than barbiturates. Alprazolam is more toxic in overdose than other benzodiazepines. Most serious cases of drug overdosage, intentional or accidental, involve polypharmacy. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions With high doses and severe toxicity, the respiratory depression from central actions of the drug may be complicated by aspiration of gastric contents in the unattended patient. This is more likely if ethanol is also present in the blood of the patient. Cardiovascular depression further complicates successful resuscitation. Airway, mechanical ventilation, maintenance of plasma volume, renal output and cardiac function! Use of dopamine or other inotropic drug is sometimes indicated to preserve renal blood flow. Hemodialysis or hemoperfusion may be used to hasten elimination of some of these drugs. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions Flumazenil reverses the sedative actions of benzodiazepines and those of eszopiclone, zaleplon and zolpidem. Duration of action is short and its antagonism of respiratory depression is unpredictable. There is a risk of precipitation of withdrawal symptoms in long-term users of benzodiazepines. The use of flumazenil in benzodiazepine overdose must be accompanied by adequate monitoring and support of respiratory function. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions The extensive clinical use of triazolam may lead to serious CNS effects: behavioral disinhibition, delirium, aggression and violence. Behavioral disinhibition may occur with any sedative-hypnotic drug. Disinhibitory reactions during benzodiazepine treatment are more clearly associated with the use of very high doses and the pretreatment level of patient´s hostility. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Direct toxic actions Hypersensitivity reactions, including skin rashes, occur only occasionally with sedative-hypnotics. FDA pregnancy category: for individual benzodiazepines is either D or X most barbiturates are D eszopiclone, ramelteon, zaleplon and zolpidem are C buspirone is B Barbiturates enhance porphyrin synthesis and are absolutely contraindicated in patients with a history of acute intermittent porphyria, variegate porphyria, hereditary coproporphyria and symptomatic porphyria. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Alterations in drug response Depending on the dosage and the duration of use, tolerance occurs in varying degrees to many of the pharmacologic effects of sedative-hypnotics. The lethal dose range is not altered significantly by the long-term use of sedative-hypnotics. Cross-tolerance between the different sedative hypnotics, including ethanol, can lead to an unsatisfactory therapeutic response. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Alterations in drug response With the long-term use of sedative-hypnotics, especially if doses are increased, a state of dependence can occur. Withdrawal from a sedative-hypnotic can have severe and life-threatening manifestations. Withdrawal symptoms range from restlessness, anxiety, weakness and orthostatic hypotension to hyperactive reflexes and generalized seizures. Symptoms of withdrawal are usually more severe following discontinuance of sedative-hypnotics with shorter half-lives. Eszopiclone, zolpidem and zaleplon are exceptions. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Alterations in drug response Symptoms of withdrawal syndrome are less pronounced with longer-acting drugs. Cross-dependence is the ability of one drug to suppress abstinence symptoms from discontinuance of another drug. It is quite marked among sedative-hypnotics. Longer-acting drugs such as chlordiazepoxide, diazepam and phenobarbital can be used to alleviate withdrawal symptoms of shorter-acting drugs, including ethanol. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Drug interactions The most common drug interactions are interactions with other CNS depressant drugs. That leads to additive effects, which can be useful in anesthesia practice. Such interactions, if not anticipated, can lead to serious consequences: enhanced depression with concomitant use of many other drugs. Additive effects can be predicted with concomitant use of alcoholic beverages, opioid analgesics, anticonvulsants and phenothiazines. Less obvious, but very important, is enhanced CNS depression with a variety of antihistamines, antihypertensive agents and antidepressant drugs of the tricyclic class. Katzung, Masters, Trevor. Basic and clinical pharmacology.

Katzung, Masters, Trevor. Basic and clinical pharmacology. Literature Katzung, Masters, Trevor. Basic and clinical pharmacology. Katzung, Masters, Trevor. Basic and clinical pharmacology.